Almirall Trades At An EV/Ebitda Of Between 11,6x And 9,53x Against 11,8x For European Sector
This week Spanish pharmaceutical firm Almirall issued a profit-warning, citing the negative impact of its US business. The stock price has dropped 30% in two days.